| Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes. | |
| | |
MedLine Citation:
|
PMID: 22499859 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: The aim of this study is to evaluate the impact of the different breast cancer subtypes on the tumor (18)F-FDG uptake at baseline and on its changes after the first course of neoadjuvant chemotherapy (NAC). PATIENTS AND METHODS: One hundred and fifteen women with newly diagnosed, large or locally advanced breast cancer undergoing NAC were included. Estrogen receptor (ER), progesterone receptor (PR) and HER2 status were used to define three major tumor subtypes: triple negative (TN) (ER-/PR-/HER2-), luminal (ER+ and/or PR+; HER2-) and HER2 positive (HER2+). Using Fluorine-18 fluorodeoxyglucose positron emission tomography, the tumoral standard uptake value (SUV) maximal index was measured at baseline and just before the second course of NAC. RESULTS: TN tumors presented the highest baseline SUV (11.3 ± 8.5; P < 0.0001). The decrease of SUV after the first course of NAC (ΔSUV) was significantly higher in TN and HER2-positive subtypes (-45% ± 25% and -57% ± 30%, respectively) than in luminal one (-19% ± 35%; P < 0.0001). ΔSUV was a predictive factor of the pathological complete response only in HER2-positive tumors (cut-off = -75%; P < 0.03) with an accuracy of 76%. CONCLUSION: The baseline (18)F-FDG tumoral uptake but also its early response to NAC is different according to the immunohistological subtypes of breast cancer. |
| | |
Authors:
|
O Humbert; A Berriolo-Riedinger; J M Riedinger; B Coudert; L Arnould; A Cochet; C Loustalot; P Fumoleau; F Brunotte |
Related Documents
:
|
9033649 - The anti-tumoral activity of human glycoprotein hgp.92: a study with the mouse lewis-lu... 6819079 - In vitro tumor cell killing by peritoneal macrophages from mitomycin c-treated rats. 15765919 - Role of inflammation in mouse lung tumorigenesis: a review. 16249029 - Microrna modulation of megakaryoblast fate involves cholinergic signaling. 22761679 - Mrl of prostate cancer antigen expression for diagnosis and lmmunotherapy. 6302639 - Iron in neoplastic disease. 9467469 - Incidence of apoptosis and metallothionein expression in renal cell carcinoma. 16097889 - Proteomics in hematologic malignancies. 8636309 - Evidence for atrophy and apoptosis in the prostates of men given finasteride. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-4-12 |
Journal Detail:
|
Title: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO Volume: - ISSN: 1569-8041 ISO Abbreviation: - Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-4-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9007735 Medline TA: Ann Oncol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Nuclear Medicine. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast canc...
Next Document: Phenotypic responses of chickens to long-term selection for high or low antibody titers to sheep red...